Choline intake and risk of lethal prostate cancer: Incidence and survival

American Journal of Clinical Nutrition

Volumn 96, Issue 4, 2012, Pages 855-863

  Richman, Erin L ^a,b   Kenfield, Stacey A ^a,c   Stampfer, Meir J ^a,c   Giovannucci, Edward L ^a,c   Zeisel, Steven H ^d   Willett, Walter C ^a   Chan, June M ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE; CHLORINE;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; MALE; PROSPECTIVE STUDY; PROSTATE CANCER;

ADULT; AGED; BETAINE; CHOLINE; COHORT STUDIES; DIET; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HEALTH PERSONNEL; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PHOSPHATIDYLCHOLINES; PHOSPHORYLCHOLINE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK; SPHINGOMYELINS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 84866594054     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.039784     Document Type: Article

References (40)

1. AICR/WCRF. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. In: AICR, ed. 2nd ed. Washington, DC: American Institute for Cancer Research/World Cancer Research Fund, 2007.
2. Chan JM, Gann PH, Giovannucci EL. Role of diet in prostate cancer development and progression. J Clin Oncol 2005;23:8152-60. (Pubitemid 46211548)
3. Dagnelie PC, Schuurman AG, Goldbohm RA, Van den Brandt PA. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int 2004;93:1139-50. (Pubitemid 38746211)
4. Richman EL, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan JM. Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival. Cancer Prev Res (Phila) 2011;4:2110-1.
5. Richman EL, Stampfer MJ, Paciorek A, Broering JM, Carroll PR, Chan JM. Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr 2010;91:712-21.
6. Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM. Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 2001;61:3599-603. (Pubitemid 32694969)
7. Johansson M, Van Guelpen B, Vollset SE, Hultdin J, Bergh A, Key T, Midttun O, Hallmans G, Ueland PM, Stattin P. One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites. Cancer Epidemiol Biomarkers Prev 2009;18:1538-43.
8. Rimm EB, Stampfer MJ, Colditz GA, Giovannucci E, Willett WC. Effectiveness of various mailing strategies among nonrespondents in a prospective cohort study. Am J Epidemiol 1990;131:1068-71. (Pubitemid 20178628)
9. USDA, Agricultural Research Service. USDA database for the choline content of common foods. Release 2. Beltsville, MD: USDA, 2008.
10. USDA, Agricultural Research Service. USDA nutrient database for standard reference. Release 13. Washington, DC: USDA, 1999.
11. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114-36.
12. Cho E, Zeisel SH, Jacques P, Selhub J, Dougherty L, Colditz GA, Willett WC. Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. Am J Clin Nutr 2006;83:905-11. (Pubitemid 44713157)
13. Stampfer MJ, Willett WC, Speizer FE, Dysert DC, Lipnick R, Rosner B, Hennekens CH. Test of the National Death Index. Am J Epidemiol 1984;119:837-9. (Pubitemid 14142821)
14. Willett WC. Nutritional epidemiology. 2nd ed. New York, NY: Oxford University Press, 1998.
15. Astorg P. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control 2004;15:367-86. (Pubitemid 38988026)
16. Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila) 2011;4:486-501.
17. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer 2007;121:1571-8. (Pubitemid 47328718)
18. Wilson KM, Kasperzyk JL, Rider JR, Kenfield SA, van Dam RM, Stampfer MJ, Giovannucci E, Mucci LA. Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. J Natl Cancer Inst 2011;103:876-84.
19. Chan JM, Giovannucci EL. Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev 2001;23:87-92. (Pubitemid 32906618)
20. Michaud DS, Augustsson K, Rimm EB, Stampfer MJ, Willet WC, Giovannucci E. A prospective study on intake of animal products and risk of prostate cancer. Cancer Causes Control 2001;12:557-67. (Pubitemid 32735128)
21. Veenema K, Solis C, Li R, Wang W, Maletz CV, Abratte CM, Caudill MA. Adequate Intake levels of choline are sufficient for preventing elevations in serum markers of liver dysfunction in Mexican American men but are not optimal for minimizing plasma total homocysteine increases after a methionine load. Am J Clin Nutr 2008;88:685-92.
22. Apolo AB, Pandit-Taskar N, Morris MJ. Novel tracers and their development for the imaging of metastatic prostate cancer. J Nucl Med 2008;49:2031-41.
23. Krause BJ, Souvatzoglou M, Tuncel M, Herrmann K, Buck AK, Praus C, Schuster T, Geinitz H, Treiber U, Schwaiger M. The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging 2008;35:18-23. (Pubitemid 350234152)
24. Keshari KR, Tsachres H, Iman R, Delos Santos L, Tabatabai ZL, Shinohara K, Vigneron DB, Kurhanewicz J. Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment. NMR Biomed 2011;24:691-9.
25. Ramirez de Molina A, Rodriguez-Gonzalez A, Gutierrez R, Martinez- Pineiro L, Sanchez J, Bonilla F, Rosell R, Lacal J. Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun 2002;296:580-3.
26. Rumsby M, Schmitt J, Sharrard M, Rodrigues G, Stower M, Maitland N. Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C. Br J Cancer 2011; 104:673-84.
27. Al-Saffar NM, Jackson LE, Raynaud FI, Clarke PA, Ramirez de Molina A, Lacal JC, Workman P, Leach MO. The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy. Cancer Res 2010;70:5507-17.
28. Raina K, Serkova NJ, Agarwal R. Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: 1H-NMRS-based metabolomics study. Cancer Res 2009;69:3731-5.
29. Tessitore L, Marengo B, Vance DE, Papotti M, Mussa A, Daidone MG, Costa A. Expression of phosphatidylethanolamine N-methyltransferase in human hepatocellular carcinomas. Oncology 2003;65:152-8. (Pubitemid 37025977)
30. Tessitore L, Dianzani I, Cui Z, Vance DE. Diminished expression of phosphatidylethanolamine N-methyltransferase 2 during hepatocarcinogenesis. Biochem J 1999;337:23-7. (Pubitemid 29039078)
31. Zeisel SH, Blusztajn JK. Choline and human nutrition. Annu Rev Nutr 1994;14:269-96. (Pubitemid 24261839)
32. Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, Burke CA, McKeown-Eyseen GE, Baron JA. Folic acid and risk of prostate cancer: results from a randomized clinical trial. J Natl Cancer Inst 2009;101:432-5.
33. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472:57-63.
34. Institute of Medicine, National Academy of Sciences. Dietary reference intakes for folate, thiamine, riboflavin, niacin, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academy of Sciences, 1998:390-422.
35. Zeisel SH, da Costa KA. Choline: an essential nutrient for public health. Nutr Rev 2009;67:615-23.
36. Eussen SJ, Ueland PM, Clarke R, Blom HJ, Hoefnagels H, van Staveren WA, de Groot LC. The association of betaine, homocysteine and related metabolites with cognitive function in Dutch elderly people. Br J Nutr 2007;98:960-8. (Pubitemid 47543454)
37. Sanchez CJ, Hooper E, Garry PJ, Goodwin JM, Goodwin JS. The relationship between dietary intake of choline, choline serum levels, and cognitive function in healthy elderly persons. J Am Geriatr Soc 1984; 32:208-12. (Pubitemid 14167908)
38. Deuster PA, Singh A, Coll R, Hyde DE, Becker WJ. Choline ingestion does not modify physical or cognitive performance. Mil Med 2002; 167:1020-5. (Pubitemid 36005196)
39. Buchman AL, Sohel M, Brown M, Jenden DJ, Ahn C, Roch M, Brawley TL. Verbal and visual memory improve after choline supplementation in long-term total parenteral nutrition: a pilot study. JPEN J Parenter Enteral Nutr 2001;25:30-5. (Pubitemid 32057756)
40. Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev 2004;CD000269.